These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
55. Differences in Progression to Obstructive Lesions per High-Risk Plaque Features and Plaque Volumes With CCTA. Lee SE; Sung JM; Andreini D; Al-Mallah MH; Budoff MJ; Cademartiri F; Chinnaiyan K; Choi JH; Chun EJ; Conte E; Gottlieb I; Hadamitzky M; Kim YJ; Lee BK; Leipsic JA; Maffei E; Marques H; de Araújo Gonçalves P; Pontone G; Raff GL; Shin S; Stone PH; Samady H; Virmani R; Narula J; Berman DS; Shaw LJ; Bax JJ; Lin FY; Min JK; Chang HJ JACC Cardiovasc Imaging; 2020 Jun; 13(6):1409-1417. PubMed ID: 31734214 [TBL] [Abstract][Full Text] [Related]
56. Reducing residual cardiovascular risk in Europe: Therapeutic implications of European medicines agency approval of icosapent ethyl/eicosapentaenoic acid. Chapman MJ; Zamorano JL; Parhofer KG Pharmacol Ther; 2022 Sep; 237():108172. PubMed ID: 35304222 [TBL] [Abstract][Full Text] [Related]
57. Rationale and design of the CONFIRM2 (Quantitative COroNary CT Angiography Evaluation For Evaluation of Clinical Outcomes: An InteRnational, Multicenter Registry) study. van Rosendael AR; Crabtree T; Bax JJ; Nakanishi R; Mushtaq S; Pontone G; Andreini D; Buechel RR; Gräni C; Feuchtner G; Patel TR; Choi AD; Al-Mallah M; Nabi F; Karlsberg RP; Rochitte CE; Alasnag M; Hamdan A; Cademartiri F; Marques H; Kalra D; German DM; Gupta H; Hadamitzky M; Deaño RC; Khalique O; Knaapen P; Hoffmann U; Earls J; Min JK; Danad I; J Cardiovasc Comput Tomogr; 2024; 18(1):11-17. PubMed ID: 37951725 [TBL] [Abstract][Full Text] [Related]
58. Coronary artery disease detected by coronary computed tomographic angiography is associated with intensification of preventive medical therapy and lower low-density lipoprotein cholesterol. Hulten E; Bittencourt MS; Singh A; O'Leary D; Christman MP; Osmani W; Abbara S; Steigner ML; Truong QA; Nasir K; Rybicki FF; Klein J; Hainer J; Brady TJ; Hoffmann U; Ghoshhajra BB; Hachamovitch R; Di Carli MF; Blankstein R Circ Cardiovasc Imaging; 2014 Jul; 7(4):629-38. PubMed ID: 24906356 [TBL] [Abstract][Full Text] [Related]
59. Plaque progression: Where, why, and how fast? A review of what we have learned from the analysis of patient data from the PARADIGM registry. Indraratna P; Khasanova E; Gulsin GS; Tzimas G; Takagi H; Park KH; Lin FY; Shaw LJ; Lee SE; Narula J; Bax JJ; Chang HJ; Leipsic J; J Cardiovasc Comput Tomogr; 2022; 16(4):294-302. PubMed ID: 34824029 [TBL] [Abstract][Full Text] [Related]
60. Maximization of the usage of coronary CTA derived plaque information using a machine learning based algorithm to improve risk stratification; insights from the CONFIRM registry. van Rosendael AR; Maliakal G; Kolli KK; Beecy A; Al'Aref SJ; Dwivedi A; Singh G; Panday M; Kumar A; Ma X; Achenbach S; Al-Mallah MH; Andreini D; Bax JJ; Berman DS; Budoff MJ; Cademartiri F; Callister TQ; Chang HJ; Chinnaiyan K; Chow BJW; Cury RC; DeLago A; Feuchtner G; Hadamitzky M; Hausleiter J; Kaufmann PA; Kim YJ; Leipsic JA; Maffei E; Marques H; Pontone G; Raff GL; Rubinshtein R; Shaw LJ; Villines TC; Gransar H; Lu Y; Jones EC; Peña JM; Lin FY; Min JK J Cardiovasc Comput Tomogr; 2018; 12(3):204-209. PubMed ID: 29753765 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]